collaborators

  • Ronald DePinho, MD

    - by Syntrix

    Partner laboratory on SX-682 prostate cancer Nature paper. Former President of MD Anderson Cancer Center.

    0

  • Martin “Mac” Cheever, MD

    - by Syntrix

    Principal Investigator of the National Cancer Institute-funded Cancer Immunotherapy Trials Network.

    0